Thermo Fisher Scientific Inc. (TMO) Stock Outlook: Latest News, Analyst Forecasts, and Key 2026 Catalysts (Dec. 25, 2025)
December 25, 2025 — Thermo Fisher Scientific Inc. (NYSE: TMO) heads into the year-end holiday period with investors balancing three big themes: fresh institutional positioning revealed in new filings, steady analyst optimism on 2026 upside, and a strategy that blends targeted M&A with deeper bets on clinical research and data-driven drug development. With U.S. equity markets closed for Christmas Day, the latest available trading data shows TMO last changing hands around the high-$570s on December 24, underscoring how closely the market is watching Thermo Fisher’s execution into early 2026—particularly as the company advances major deals and integrates recently acquired assets.